Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.
|
J Antimicrob Chemother
|
1997
|
2.47
|
2
|
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.
|
Clin Infect Dis
|
1998
|
2.38
|
3
|
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries.
|
Epidemiol Infect
|
2000
|
1.97
|
4
|
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.
|
J Antimicrob Chemother
|
2001
|
1.68
|
5
|
Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis.
|
Trends Mol Med
|
2001
|
1.65
|
6
|
Challenge model for Helicobacter pylori infection in human volunteers.
|
Gut
|
2004
|
1.57
|
7
|
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
|
Dig Liver Dis
|
2004
|
1.51
|
8
|
The effects of freezing and antibiotics on the viability of Acanthamoeba cysts.
|
Arch Ophthalmol
|
1989
|
1.42
|
9
|
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.
|
Antimicrob Agents Chemother
|
2000
|
1.42
|
10
|
Isolation of Helicobacter pylori from sheep-implications for transmission to humans.
|
Am J Gastroenterol
|
2001
|
1.40
|
11
|
Amoxycillin tolerance in Helicobacter pylori.
|
J Antimicrob Chemother
|
1999
|
1.38
|
12
|
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.
|
Antimicrob Agents Chemother
|
2000
|
1.19
|
13
|
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan.
|
Antimicrob Agents Chemother
|
2000
|
1.18
|
14
|
Rapid diagnosis of Acanthamoeba keratitis using calcofluor white.
|
Arch Ophthalmol
|
1986
|
1.13
|
15
|
Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas.
|
J Infect Dis
|
2000
|
1.12
|
16
|
DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates.
|
Antimicrob Agents Chemother
|
2001
|
1.11
|
17
|
Furazolidone combination therapies for Helicobacter pylori infection in the United States.
|
Aliment Pharmacol Ther
|
2000
|
1.09
|
18
|
Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study.
|
Gastrointest Endosc
|
1999
|
1.06
|
19
|
Bacterial contamination of eyedrop dispensers.
|
Am J Ophthalmol
|
1984
|
1.05
|
20
|
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance.
|
Antimicrob Agents Chemother
|
2001
|
1.04
|
21
|
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis.
|
Aliment Pharmacol Ther
|
2003
|
1.03
|
22
|
Helicobacter pylori in sheep milk.
|
Lancet
|
1999
|
1.00
|
23
|
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
|
Aliment Pharmacol Ther
|
2003
|
0.96
|
24
|
Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates.
|
J Antimicrob Chemother
|
2000
|
0.96
|
25
|
Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance.
|
FEMS Microbiol Lett
|
2000
|
0.94
|
26
|
Experimental evaluation of chlorhexidine gluconate for ocular antisepsis.
|
Antimicrob Agents Chemother
|
1984
|
0.92
|
27
|
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection.
|
Helicobacter
|
1998
|
0.92
|
28
|
H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori.
|
Am J Gastroenterol
|
2000
|
0.92
|
29
|
Infectious crystalline keratopathy. The role of bacterial exopolysaccharide.
|
Arch Ophthalmol
|
1993
|
0.90
|
30
|
Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins.
|
Antimicrob Agents Chemother
|
1999
|
0.88
|
31
|
In vitro susceptibilities of ocular Bacillus cereus isolates to clindamycin, gentamicin, and vancomycin alone or in combination.
|
Antimicrob Agents Chemother
|
1991
|
0.88
|
32
|
Characterization of a culture method to recover Helicobacter pylori from the feces of infected patients.
|
Helicobacter
|
2000
|
0.86
|
33
|
Helicobacter pylori infection in children of Texas.
|
J Pediatr Gastroenterol Nutr
|
2000
|
0.86
|
34
|
The value of calcofluor white in the diagnosis of mycotic and Acanthamoeba infections of the eye and ocular adnexa.
|
Ophthalmology
|
1987
|
0.86
|
35
|
The contribution of bacterial surface hydrophobicity to the process of adherence of Pseudomonas aeruginosa to hydrophilic contact lenses.
|
Curr Eye Res
|
1989
|
0.86
|
36
|
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
|
Aliment Pharmacol Ther
|
2000
|
0.85
|
37
|
Novel therapies for Helicobacter pylori infection.
|
Aliment Pharmacol Ther
|
1999
|
0.85
|
38
|
The autoimmune nature of aqueous tear deficiency.
|
Ophthalmology
|
1986
|
0.85
|
39
|
Failure to isolate Helicobacter pylori from stray cats indicates that H. pylori in cats may be an anthroponosis--an animal infection with a human pathogen.
|
J Med Microbiol
|
1997
|
0.84
|
40
|
Comparative bioavailability and efficacy of fortified topical tobramycin.
|
Invest Ophthalmol Vis Sci
|
1987
|
0.84
|
41
|
Endogenous Candida albicans endophthalmitis in the rabbit. Chemotherapy for systemic effect.
|
Arch Ophthalmol
|
1981
|
0.83
|
42
|
Direct activity of recombinant human lactoferrin against Helicobacter pylori.
|
J Clin Microbiol
|
1996
|
0.83
|
43
|
Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying.
|
Aliment Pharmacol Ther
|
2001
|
0.83
|
44
|
Improved detection of oculomycoses using induced fluorescence with cellufluor.
|
Ophthalmology
|
1986
|
0.80
|
45
|
Quantitative and bioluminescent assay to measure efficacy of conventional and DNA vaccinations against Helicobacter pylori.
|
Comb Chem High Throughput Screen
|
2000
|
0.80
|
46
|
Tobramycin in ophthalmology.
|
Surv Ophthalmol
|
1988
|
0.80
|
47
|
Comparison of acridine orange and Gram stains in bacterial keratitis.
|
Am J Ophthalmol
|
1988
|
0.79
|
48
|
Quantitative RT-PCR analysis of multiple genes encoding putative metronidazole nitroreductases from Helicobacter pylori.
|
Int J Antimicrob Agents
|
2000
|
0.79
|
49
|
Capnocytophaga keratitis.
|
Br J Ophthalmol
|
1985
|
0.79
|
50
|
Folk yoghurt kills Helicobacter pylori.
|
J Appl Microbiol
|
2002
|
0.78
|
51
|
Neurotoxicity of iohexol: a new nonionic contrast medium.
|
Radiology
|
1982
|
0.78
|
52
|
Is antrum or corpus the best site for culture of Helicobacter pylori?
|
Helicobacter
|
1996
|
0.78
|
53
|
Culture of Helicobacter pylori: effect of preimmersion of biopsy forceps in formalin.
|
Helicobacter
|
1996
|
0.77
|
54
|
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
|
Aliment Pharmacol Ther
|
2001
|
0.77
|
55
|
Use of a dry-plasma collection device to overcome problems with storage and transportation of blood samples for epidemiology studies in developing countries.
|
Clin Diagn Lab Immunol
|
2000
|
0.75
|
56
|
Laundry brighteners and amebic cysts.
|
N Engl J Med
|
1994
|
0.75
|
57
|
Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis.
|
Aust N Z J Ophthalmol
|
1993
|
0.75
|
58
|
Disinfection of biopsy forceps and culture of Helicobacter pylori from gastric mucosal biopsies.
|
Am J Gastroenterol
|
1999
|
0.75
|
59
|
Rapid streptococcal antigen detection in experimental keratitis.
|
Am J Ophthalmol
|
1989
|
0.75
|
60
|
Photomicrography of Acanthamoeba cysts in human cornea.
|
Am J Ophthalmol
|
1988
|
0.75
|
61
|
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
|
Dig Dis Sci
|
1998
|
0.75
|
62
|
Combination drug testing of Mycobacterium chelonae.
|
Invest Ophthalmol Vis Sci
|
1993
|
0.75
|
63
|
Intracanalicular collagen implants enhance topical antibiotic bioavailability.
|
Cornea
|
1986
|
0.75
|
64
|
The effects of fibronectin on the adherence of bacteria to corneal epithelium.
|
Cornea
|
1991
|
0.75
|
65
|
The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates--correction.
|
Am J Ophthalmol
|
1991
|
0.75
|
66
|
The solubility of antibiotic and corticosteroid combinations.
|
Am J Ophthalmol
|
1992
|
0.75
|
67
|
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.
|
Aliment Pharmacol Ther
|
1999
|
0.75
|